MRI for the assessment and monitoring of RA-what can it tell us?

Nature Reviews Rheumatology

Volumn 7, Issue 3, 2011, Pages 185-189

  McGonagle, Dennis ^a   Ash, Zoe R ^a   Hodgson, Richard J ^a   Emery, Paul ^a   Radjenovic, Aleksandra ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY;

DIAGNOSTIC IMAGING; HUMAN; JOINT INJURY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PATHOGENESIS; PATIENT ASSESSMENT; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RHEUMATOID ARTHRITIS; SYNOVITIS;

ARTHRITIS, RHEUMATOID; DIAGNOSIS, DIFFERENTIAL; HUMANS; JOINTS; MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; SYNOVITIS;

EID: 79952449109     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2010.172     Document Type: Review

References (39)

1. Hetland, M. L. et al. MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (cIMesTRA). Ann. Rheum. Dis. 68, 384-390 (2009).
2. Sugimoto, H., Takeda, A., Masuyama, J. & Furuse, M. early-stage rheumatoid arthritis: diagnostic accuracy of MR imaging. Radiology 198, 185-192 (1996). (Pubitemid 26008262)
3. Brown, A. K. et al. An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum. 58, 2958-2967 (2008).
4. Wakefield, R. J. et al. should oligoarthritis be reclassified? Ultrasound reveals a high prevalence of subclinical disease. Ann. Rheum. Dis. 63, 382-385 (2004). (Pubitemid 38453303)
5. Dohn, U. M. et al. Are bone erosions detected by magnetic resonance imaging and ultrasonography true erosions? A comparison with computed tomography in rheumatoid arthritis metacarpophalangeal joints. Arthritis Res. Ther. 8, R110 (2006).
6. McGonagle, D. et al. The relationship between synovitis and bone changes in early untreated rheumatoid arthritis: a controlled magnetic resonance imaging study. Arthritis Rheum. 42, 1706-1711 (1999) (Pubitemid 30263640)
7. Østergaard, M. et al. New radiographic bone erosions in the wrists of patients with rheumatoid arthritis are detectable with magnetic resonance imaging a median of two years earlier. Arthritis Rheum. 48, 2128-2131 (2003). (Pubitemid 36959192)
8. Dalbeth, N. et al. cellular characterisation of magnetic resonance imaging bone oedema in rheumatoid arthritis; implications for pathogenesis of erosive disease. Ann. Rheum. Dis. 68, 279-282 (2009).
9. McQueen, F. M. et al. Bone edema scored on magnetic resonance imaging scans of the dominant carpus at presentation predicts radiographic joint damage of the hands and feet six years later in patients with rheumatoid arthritis. Arthritis Rheum. 48, 1814-1827 (2003). (Pubitemid 36828675)
10. Tamai, M. et al. A prediction rule for disease outcome in patients with undifferentiated arthritis using magnetic resonance imaging of the wrists and finger joints and serologic autoantibodies. Arthritis Rheum. 61, 772-778 (2009).
11. Ostergaard, M. et al. Magnetic resonance maging-determined synovial membrane volume as a marker of disease activity and a predictor of progressive joint destruction in the wrists of patients with rheumatoid arthritis. Arthritis Rheum. 42, 918-929 (1999). (Pubitemid 29215002)
12. Døhn, U. M. et al. Tendency towards erosive regression on magnetic resonance imaging at 12 months in rheumatoid arthritis patients treated with rituximab. Ann. Rheum. Dis. 68, 1072-1073 (2009).
13. Tan, A. L et al. Role of metacarpophalangeal joint anatomic factors in the distribution of synovitis and bone erosion in early rheumatoid arthritis. Arthritis Rheum. 48, 1214-1222 (2003). (Pubitemid 36554520)
14. Marzo-Ortega, H. et al. Magnetic resonance maging in the assessment of metacarpophalangeal joint disease in early psoriatic and rheumatoid arthritis. Scand. J. Rheumatol. 38, 79-83 (2009).
15. Marzo-Ortega, H. et al. evidence for a different anatomic basis for joint disease localization in polymyalgia rheumatica in comparison with rheumatoid arthritis. Arthritis Rheum. 56, 3496-3501 (2007). (Pubitemid 47585446)
16. Tan, A. L et al. combined high-resolution magnetic resonance imaging and histological examination to explore the role of ligaments and tendons in the phenotypic expression of early hand osteoarthritis. Ann. Rheum. Dis. 65, 1267-1272 (2006). (Pubitemid 44620435)
17. Stach, C. M. et al. Periarticular bone structure in rheumatoid arthritis patients and healthy individuals assessed by high resolution computed tomography Arthritis Rheum. 62, 330-339 (2010).
18. McGonagle, D., Tan, A. L., Møller Døhn, U., Ostergaard, M. & Benjamin, M. Microanatomic studies to define predictive factors for the topography of periarticular erosion formation in inflammatory arthritis. Arthritis Rheum. 60, 1042-1051 (2009)
19. Haavardsholm, E. A. et al. Reliability and sensitivity to change of the OMeRAcT rheumatoid arthritis magnetic resonance maging score in a multireader, longitudinal setting. Arthritis Rheum. 52, 3860-3867 (2005). (Pubitemid 41798224)
20. Polisson, R. P et al. Use of magnetic resonance imaging and positron emission tomography in the assessment of synovial volume and glucose metabolism in patients with rheumatoid arthritis. Arthritis Rheum. 38, 819-825 (1995).
21. Ostergaard, M. et al. changes in synovial membrane and joint effusion volumes after intraarticular methylprednisolone. Quantitative assessment of inflammatory and destructive changes in arthritis by MRI. J. Rheumatol. 23, 1151-1161 (1996).
22. Quinn, M. A. et al. very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 52, 27-35 (2005). (Pubitemid 40129229)
23. Huang, J. et al. A 1-year follow-up study of dynamic magnetic resonance imaging in early rheumatoid arthritis reveals synovitis to be increased in shared epitope-positive patients and predictive of erosions at 1 year. Rheumatology (Oxford) 39, 407-416 (2000) (Pubitemid 30307327)
24. Jarrett, S. J. et al. Preliminary evidence for a structural benefit of the new bisphosphonate zoledronic acid in early rheumatoid arthritis. Arthritis Rheum. 54, 1410-1414 (2006).
25. Narvaez, J. et al. Usefulness of magnetic resonance imaging of the hand versus anticyclic citrullinated peptide antibody testing to confirm the diagnosis of clinically suspected early rheumatoid arthritis in the absence of rheumatoid factor and radiographic erosions. Semin. Arthritis Rheum. 38, 101-109 (2008).
26. McGonagle, D., Gibbon, W. & Emery, P. classification of inflammatory arthritis by enthesitis. Lancet 352, 1137-1140 (1998). (Pubitemid 28448530)
27. Tan, A. L., Grainger, A. J., Tanner, S. F., Emery, P. & McGonagle, D. A high-resolution magnetic resonance imaging study of distal interphalangeal joint arthropathy in psoriatic arthritis and osteoarthritis: are they the same? Arthritis Rheum. 54, 1328-1333 (2006). (Pubitemid 43672946)
28. Freeston, J. E. et al. A diagnostic algorithm for persistence of very early inflammatory arthritis: the utility of power doppler ultrasound when added to conventional assessment tools. Ann. Rheum. Dis. 69, 417-419 (2010).
29. Carson, D. A. & Haneji, N. Fighting arthritis with a senescence gene. Nat Med. 5, 731-732 (1999). (Pubitemid 29318598)
30. McGonagle, D. & Tan, A. L. What magnetic resonance imaging has told us about the pathogenesis of rheumatoid arthritis\the first 50 years. Arthritis Res. Ther. 10, 222 (2008).
31. Hirose, W. Nishikawa, K., Hirose, M., Nanki, T. & Sugimoto, H. Response of early active rheumatoid arthritis to tumor necrosis factor inhibitors: evaluation by magnetic resonance maging. Mod. Rheumatol. 19, 20-26 (2009).
32. Rhodes, L. A. et al. Regional variation and differential response to therapy for knee synovitis adjacent to the cartilage-pannus junction and suprapatellar pouch in inflammatory arthritis: implications for pathogenesis and treatment. Arthritis Rheum. 50, 2428-2432 (2004). (Pubitemid 39062701)
33. Gasson, J. et al. Magnetic resonance imaging of rheumatoid arthritis in metacarpophalangeal joints. Skeletal Radiol. 29, 324-334 (2000). (Pubitemid 30421031)
34. Du, J., Takahashi, A. M. & Chung, C. B. Ultrashort Te spectroscopic imaging (UTesI): application to the imaging of short T2 relaxation tissues in the musculoskeletal system. J. Magn. Reson. Imaging 29, 412-421 (2009).
35. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1, 27-31 (1995).
36. Tofts, P. S. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J. Magn. Reson. Imaging 7, 91-101 (1997). (Pubitemid 28365643)
37. Hodgson, R. J. et al. Pharmacokinetic modeling of dynamic contrast-enhanced MRI of the hand and wrist in rheumatoid arthritis and the response to anti-tumor necrosis factor-alpha therapy. Magn. Reson. Med. 58, 482-489 (2007). (Pubitemid 350154958)
38. Radjenovic, A. Measurement of physiological variables by dynamic Gd-DTPA enhanced MRI. Thesis, University of Leeds (2003).
39. Reece, R. J. et al. comparative assessment of leflunomide and methotrexate for the treatment of rheumatoid arthritis, by dynamic enhanced magnetic resonance imaging. Arthritis Rheum. 46, 366-372 (2002). (Pubitemid 34136573)